Literature DB >> 21585434

Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.

Miriam Lenhard, Tereza Lennerová, Nina Ditsch, Steffen Kahlert, Klaus Friese, Doris Mayr, Udo Jeschke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21585434     DOI： 10.1111/j.1365-2559.2011.03848.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  16 in total

Review 1.  Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?

Authors:  Konstantinos Papadimitriou; Panteleimon Kountourakis; Anastasia E Kottorou; Anna G Antonacopoulou; Christian Rolfo; Marc Peeters; Haralabos P Kalofonos
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

2.  p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer.

Authors:  Sabine Heublein; Sabina K Page; Doris Mayr; Nina Ditsch; Udo Jeschke
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-02       Impact factor: 4.553

3.  Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.

Authors:  Miriam Lenhard; Alexandra Tsvilina; Lan Schumacher; Markus Kupka; Nina Ditsch; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-01-03       Impact factor: 4.430

4.  Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.

Authors:  Sabine Heublein; Doris Mayr; Alfons Meindl; Martin Angele; Julia Gallwas; Udo Jeschke; Nina Ditsch
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

5.  The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.

Authors:  Sabine Heublein; Doris Mayr; Thomas Vrekoussis; Klaus Friese; Simone S Hofmann; Udo Jeschke; Miriam Lenhard
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

6.  Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.

Authors:  Sabine Heublein; Doris Mayr; Alfons Meindl; Alexandra Kircher; Udo Jeschke; Nina Ditsch
Journal:  J Exp Clin Cancer Res       Date:  2017-04-20

7.  Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

Authors:  Miriam Lenhard; Lennerová Tereza; Sabine Heublein; Nina Ditsch; Isabelle Himsl; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-11-24       Impact factor: 4.430

8.  Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.

Authors:  Christoph Scholz; Sabine Heublein; Miriam Lenhard; Klaus Friese; Doris Mayr; Udo Jeschke
Journal:  BMC Res Notes       Date:  2012-10-05

9.  Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR).

Authors:  Sabine Heublein; Thomas Vrekoussis; Doris Mayr; Klaus Friese; Miriam Lenhard; Udo Jeschke; Darius Dian
Journal:  J Ovarian Res       Date:  2013-01-22       Impact factor: 4.234

10.  The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.

Authors:  Sabine Heublein; Doris Mayr; Klaus Friese; Maria Cristina Jarrin-Franco; Miriam Lenhard; Artur Mayerhofer; Udo Jeschke
Journal:  Int J Mol Sci       Date:  2014-08-27       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.